A Randomized Pilot Study of Low-Fluence Photodynamic Therapy Versus Intravitreal Ranibizumab for Chronic Central Serous Chorioretinopathy

In terms of anatomic outcomes, the effect of ranibizumab injections was not promising compared with that of low-fluence PDT.